nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.125	0.167	CbGbCtD
Fidaxomicin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.113	0.151	CbGbCtD
Fidaxomicin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0973	0.131	CbGbCtD
Fidaxomicin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0944	0.127	CbGbCtD
Fidaxomicin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0854	0.115	CbGbCtD
Fidaxomicin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0854	0.115	CbGbCtD
Fidaxomicin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0819	0.11	CbGbCtD
Fidaxomicin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0633	0.085	CbGbCtD
Fidaxomicin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000849	0.00333	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000848	0.00333	CcSEcCtD
Fidaxomicin—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000844	0.00331	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000838	0.00329	CcSEcCtD
Fidaxomicin—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000838	0.00329	CcSEcCtD
Fidaxomicin—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.000838	0.00329	CcSEcCtD
Fidaxomicin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000834	0.00327	CcSEcCtD
Fidaxomicin—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000833	0.00327	CcSEcCtD
Fidaxomicin—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000827	0.00324	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000823	0.00323	CcSEcCtD
Fidaxomicin—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000823	0.00323	CcSEcCtD
Fidaxomicin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000821	0.00322	CcSEcCtD
Fidaxomicin—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000814	0.00319	CcSEcCtD
Fidaxomicin—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000809	0.00317	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000809	0.00317	CcSEcCtD
Fidaxomicin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000806	0.00316	CcSEcCtD
Fidaxomicin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.000802	0.00315	CcSEcCtD
Fidaxomicin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0008	0.00314	CcSEcCtD
Fidaxomicin—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000799	0.00314	CcSEcCtD
Fidaxomicin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000798	0.00313	CcSEcCtD
Fidaxomicin—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000798	0.00313	CcSEcCtD
Fidaxomicin—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000797	0.00313	CcSEcCtD
Fidaxomicin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000794	0.00311	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000792	0.00311	CcSEcCtD
Fidaxomicin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000786	0.00308	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000774	0.00304	CcSEcCtD
Fidaxomicin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000769	0.00302	CcSEcCtD
Fidaxomicin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000758	0.00297	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000756	0.00297	CcSEcCtD
Fidaxomicin—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000753	0.00295	CcSEcCtD
Fidaxomicin—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000752	0.00295	CcSEcCtD
Fidaxomicin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000748	0.00293	CcSEcCtD
Fidaxomicin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000744	0.00292	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00074	0.0029	CcSEcCtD
Fidaxomicin—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00074	0.0029	CcSEcCtD
Fidaxomicin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000736	0.00289	CcSEcCtD
Fidaxomicin—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000735	0.00288	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000735	0.00288	CcSEcCtD
Fidaxomicin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000734	0.00288	CcSEcCtD
Fidaxomicin—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000725	0.00285	CcSEcCtD
Fidaxomicin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000725	0.00284	CcSEcCtD
Fidaxomicin—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000723	0.00284	CcSEcCtD
Fidaxomicin—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000722	0.00283	CcSEcCtD
Fidaxomicin—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00072	0.00283	CcSEcCtD
Fidaxomicin—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000716	0.00281	CcSEcCtD
Fidaxomicin—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000714	0.0028	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000711	0.00279	CcSEcCtD
Fidaxomicin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.00279	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000709	0.00278	CcSEcCtD
Fidaxomicin—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000706	0.00277	CcSEcCtD
Fidaxomicin—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000704	0.00276	CcSEcCtD
Fidaxomicin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000703	0.00276	CcSEcCtD
Fidaxomicin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000702	0.00276	CcSEcCtD
Fidaxomicin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.0007	0.00275	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000699	0.00274	CcSEcCtD
Fidaxomicin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000697	0.00274	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000696	0.00273	CcSEcCtD
Fidaxomicin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000694	0.00272	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000688	0.0027	CcSEcCtD
Fidaxomicin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00068	0.00267	CcSEcCtD
Fidaxomicin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.00267	CcSEcCtD
Fidaxomicin—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000679	0.00266	CcSEcCtD
Fidaxomicin—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000678	0.00266	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000674	0.00264	CcSEcCtD
Fidaxomicin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000673	0.00264	CcSEcCtD
Fidaxomicin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000672	0.00264	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000672	0.00264	CcSEcCtD
Fidaxomicin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00067	0.00263	CcSEcCtD
Fidaxomicin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00067	0.00263	CcSEcCtD
Fidaxomicin—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000666	0.00261	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000662	0.0026	CcSEcCtD
Fidaxomicin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00066	0.00259	CcSEcCtD
Fidaxomicin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000655	0.00257	CcSEcCtD
Fidaxomicin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000655	0.00257	CcSEcCtD
Fidaxomicin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000654	0.00257	CcSEcCtD
Fidaxomicin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000651	0.00256	CcSEcCtD
Fidaxomicin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000651	0.00255	CcSEcCtD
Fidaxomicin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00065	0.00255	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00065	0.00255	CcSEcCtD
Fidaxomicin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000649	0.00255	CcSEcCtD
Fidaxomicin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000648	0.00254	CcSEcCtD
Fidaxomicin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000645	0.00253	CcSEcCtD
Fidaxomicin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000645	0.00253	CcSEcCtD
Fidaxomicin—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000641	0.00252	CcSEcCtD
Fidaxomicin—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00064	0.00251	CcSEcCtD
Fidaxomicin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00064	0.00251	CcSEcCtD
Fidaxomicin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000637	0.0025	CcSEcCtD
Fidaxomicin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.00247	CcSEcCtD
Fidaxomicin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000629	0.00247	CcSEcCtD
Fidaxomicin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000627	0.00246	CcSEcCtD
Fidaxomicin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.00245	CcSEcCtD
Fidaxomicin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000621	0.00244	CcSEcCtD
Fidaxomicin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000617	0.00242	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000616	0.00242	CcSEcCtD
Fidaxomicin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000615	0.00241	CcSEcCtD
Fidaxomicin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000615	0.00241	CcSEcCtD
Fidaxomicin—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000612	0.0024	CcSEcCtD
Fidaxomicin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000612	0.0024	CcSEcCtD
Fidaxomicin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000611	0.0024	CcSEcCtD
Fidaxomicin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000609	0.00239	CcSEcCtD
Fidaxomicin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000607	0.00238	CcSEcCtD
Fidaxomicin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000605	0.00237	CcSEcCtD
Fidaxomicin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.00237	CcSEcCtD
Fidaxomicin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000602	0.00236	CcSEcCtD
Fidaxomicin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000602	0.00236	CcSEcCtD
Fidaxomicin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000597	0.00234	CcSEcCtD
Fidaxomicin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000596	0.00234	CcSEcCtD
Fidaxomicin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000596	0.00234	CcSEcCtD
Fidaxomicin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000593	0.00233	CcSEcCtD
Fidaxomicin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000592	0.00232	CcSEcCtD
Fidaxomicin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000585	0.00229	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000584	0.00229	CcSEcCtD
Fidaxomicin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000583	0.00229	CcSEcCtD
Fidaxomicin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000583	0.00229	CcSEcCtD
Fidaxomicin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000581	0.00228	CcSEcCtD
Fidaxomicin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000577	0.00226	CcSEcCtD
Fidaxomicin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.00226	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.00226	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000573	0.00225	CcSEcCtD
Fidaxomicin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000573	0.00225	CcSEcCtD
Fidaxomicin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000571	0.00224	CcSEcCtD
Fidaxomicin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000568	0.00223	CcSEcCtD
Fidaxomicin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000566	0.00222	CcSEcCtD
Fidaxomicin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000564	0.00221	CcSEcCtD
Fidaxomicin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000562	0.00221	CcSEcCtD
Fidaxomicin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000559	0.00219	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000554	0.00217	CcSEcCtD
Fidaxomicin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000552	0.00217	CcSEcCtD
Fidaxomicin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000545	0.00214	CcSEcCtD
Fidaxomicin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000545	0.00214	CcSEcCtD
Fidaxomicin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000545	0.00214	CcSEcCtD
Fidaxomicin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000544	0.00214	CcSEcCtD
Fidaxomicin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000543	0.00213	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000543	0.00213	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000542	0.00212	CcSEcCtD
Fidaxomicin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000541	0.00212	CcSEcCtD
Fidaxomicin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000539	0.00212	CcSEcCtD
Fidaxomicin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000537	0.0021	CcSEcCtD
Fidaxomicin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000537	0.0021	CcSEcCtD
Fidaxomicin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000536	0.0021	CcSEcCtD
Fidaxomicin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000535	0.0021	CcSEcCtD
Fidaxomicin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000535	0.0021	CcSEcCtD
Fidaxomicin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000533	0.00209	CcSEcCtD
Fidaxomicin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000528	0.00207	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000528	0.00207	CcSEcCtD
Fidaxomicin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000525	0.00206	CcSEcCtD
Fidaxomicin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000524	0.00206	CcSEcCtD
Fidaxomicin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000524	0.00206	CcSEcCtD
Fidaxomicin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000522	0.00205	CcSEcCtD
Fidaxomicin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000522	0.00205	CcSEcCtD
Fidaxomicin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00052	0.00204	CcSEcCtD
Fidaxomicin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00052	0.00204	CcSEcCtD
Fidaxomicin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000519	0.00204	CcSEcCtD
Fidaxomicin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000519	0.00204	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000518	0.00203	CcSEcCtD
Fidaxomicin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000518	0.00203	CcSEcCtD
Fidaxomicin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000518	0.00203	CcSEcCtD
Fidaxomicin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000516	0.00203	CcSEcCtD
Fidaxomicin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000515	0.00202	CcSEcCtD
Fidaxomicin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000515	0.00202	CcSEcCtD
Fidaxomicin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000513	0.00201	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000513	0.00201	CcSEcCtD
Fidaxomicin—Rash—Abacavir—acquired immunodeficiency syndrome	0.00051	0.002	CcSEcCtD
Fidaxomicin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00051	0.002	CcSEcCtD
Fidaxomicin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000507	0.00199	CcSEcCtD
Fidaxomicin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000505	0.00198	CcSEcCtD
Fidaxomicin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000505	0.00198	CcSEcCtD
Fidaxomicin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0005	0.00196	CcSEcCtD
Fidaxomicin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000496	0.00195	CcSEcCtD
Fidaxomicin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000495	0.00194	CcSEcCtD
Fidaxomicin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000495	0.00194	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000491	0.00193	CcSEcCtD
Fidaxomicin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00049	0.00192	CcSEcCtD
Fidaxomicin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000489	0.00192	CcSEcCtD
Fidaxomicin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000489	0.00192	CcSEcCtD
Fidaxomicin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000488	0.00191	CcSEcCtD
Fidaxomicin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000483	0.00189	CcSEcCtD
Fidaxomicin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000481	0.00189	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000479	0.00188	CcSEcCtD
Fidaxomicin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000476	0.00187	CcSEcCtD
Fidaxomicin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000475	0.00186	CcSEcCtD
Fidaxomicin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000475	0.00186	CcSEcCtD
Fidaxomicin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000472	0.00185	CcSEcCtD
Fidaxomicin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00047	0.00185	CcSEcCtD
Fidaxomicin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00047	0.00184	CcSEcCtD
Fidaxomicin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000465	0.00182	CcSEcCtD
Fidaxomicin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000462	0.00181	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000461	0.00181	CcSEcCtD
Fidaxomicin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000457	0.00179	CcSEcCtD
Fidaxomicin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000454	0.00178	CcSEcCtD
Fidaxomicin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000454	0.00178	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.00178	CcSEcCtD
Fidaxomicin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00045	0.00177	CcSEcCtD
Fidaxomicin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00045	0.00176	CcSEcCtD
Fidaxomicin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000449	0.00176	CcSEcCtD
Fidaxomicin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00175	CcSEcCtD
Fidaxomicin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00174	CcSEcCtD
Fidaxomicin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000443	0.00174	CcSEcCtD
Fidaxomicin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000442	0.00174	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00044	0.00173	CcSEcCtD
Fidaxomicin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000439	0.00172	CcSEcCtD
Fidaxomicin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000439	0.00172	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.00171	CcSEcCtD
Fidaxomicin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000436	0.00171	CcSEcCtD
Fidaxomicin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00167	CcSEcCtD
Fidaxomicin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000424	0.00166	CcSEcCtD
Fidaxomicin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000422	0.00166	CcSEcCtD
Fidaxomicin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000422	0.00166	CcSEcCtD
Fidaxomicin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000419	0.00164	CcSEcCtD
Fidaxomicin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000418	0.00164	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.00164	CcSEcCtD
Fidaxomicin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000416	0.00163	CcSEcCtD
Fidaxomicin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000415	0.00163	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000409	0.0016	CcSEcCtD
Fidaxomicin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.00158	CcSEcCtD
Fidaxomicin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00156	CcSEcCtD
Fidaxomicin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.00156	CcSEcCtD
Fidaxomicin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.00155	CcSEcCtD
Fidaxomicin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00155	CcSEcCtD
Fidaxomicin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000394	0.00155	CcSEcCtD
Fidaxomicin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000394	0.00154	CcSEcCtD
Fidaxomicin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000393	0.00154	CcSEcCtD
Fidaxomicin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00154	CcSEcCtD
Fidaxomicin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000382	0.0015	CcSEcCtD
Fidaxomicin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00148	CcSEcCtD
Fidaxomicin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00148	CcSEcCtD
Fidaxomicin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00148	CcSEcCtD
Fidaxomicin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.00148	CcSEcCtD
Fidaxomicin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000376	0.00147	CcSEcCtD
Fidaxomicin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000373	0.00146	CcSEcCtD
Fidaxomicin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00144	CcSEcCtD
Fidaxomicin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00141	CcSEcCtD
Fidaxomicin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000357	0.0014	CcSEcCtD
Fidaxomicin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00139	CcSEcCtD
Fidaxomicin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00138	CcSEcCtD
Fidaxomicin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00137	CcSEcCtD
Fidaxomicin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00137	CcSEcCtD
Fidaxomicin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00136	CcSEcCtD
Fidaxomicin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00133	CcSEcCtD
Fidaxomicin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00132	CcSEcCtD
Fidaxomicin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00132	CcSEcCtD
Fidaxomicin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00132	CcSEcCtD
Fidaxomicin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00131	CcSEcCtD
Fidaxomicin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00129	CcSEcCtD
Fidaxomicin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00127	CcSEcCtD
Fidaxomicin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00126	CcSEcCtD
Fidaxomicin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00126	CcSEcCtD
Fidaxomicin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.00125	CcSEcCtD
Fidaxomicin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00125	CcSEcCtD
Fidaxomicin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00119	CcSEcCtD
